--2025/Q1-- / 40.734M--
--2024/Q4-- / 40.387M--
Nov 7, 20242024/Q335.314M / 35.071M--
Aug 5, 20242024/Q234.887M / 32.100M--
May 6, 20242024/Q129.512M / 27.559M--
US Stock MarketDetailed Quotes
RXST RxSight
- 37.070
- -0.510-1.36%
Trading Dec 12 10:47 ET
1.49BMarket Cap-45.77P/E (TTM)
37.898High36.500Low125.81KVolume36.910Open37.580Pre Close4.70MTurnover0.37%Turnover RatioLossP/E (Static)40.25MShares66.54052wk High5.38P/B1.27BFloat Cap34.92052wk Low--Dividend TTM34.34MShs Float66.540Historical High--Div YieldTTM3.72%Amplitude8.800Historical Low37.325Avg Price1Lot Size
RxSight Key Stats
RxSight Q3 2024 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 35.07M | 35.31M | +242.88K |
| Beat Est. | +57.99% | +59.08% | +0.69% |
| EPS | -0.25 | -0.16 | +0.09 |
| Beat Est. | +29.55% | +54.29% | +35.09% |
Analyst Rating
Dec 11, 2024
RxSight Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
RxSight Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data